Robert Francomano - Insider Trading & Ownership

Entity
Individual
Location
C/O Stemline Therapeutics, Inc., 750 Lexington Avenue, 11 Th Floor, New York, NY
Summary
The estimated net worth of Robert Francomano is at least $278K dollars as of January 25, 2024. Robert Francomano is the Chief Commercial Officer of SELLAS Life Sciences Group, Inc. and owns shares of SELLAS Life Sciences Group, Inc. (SLS) stock worth about $278K.
All Insider Reports
All Insider Reports

Ownership of Robert Francomano

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SLS SELLAS Life Sciences Group, Inc. Chief Commercial Officer $278K Jan 22, 2024

Insider Transactions Reported by Robert Francomano:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.